Photodynamic therapy and endoscopic mucosal resection for Barrett's dysplasia and early esophageal adenocarcinoma

Southern Medical Journal

Volumn 97, Issue 9, 2004, Pages 827-830

  Wolfsen, H C ^a   Hemminger, Lois L ^a   Raimondo, Massimo ^a   Woodward, Timothy A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Barrett's esophagus; Endoscopic mucosal resection; Endoscopic ultrasound; Esophageal cancer; Photodynamic therapy

Indexed keywords

AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER DIAGNOSIS; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DYSPHAGIA; DYSPLASIA; ENDOSCOPIC SURGERY; ESOPHAGOSCOPY; ESOPHAGUS CARCINOMA; ESOPHAGUS SURGERY; HUMAN; MALE; ODYNOPHAGIA; PHOTODYNAMIC THERAPY; THORAX PAIN; TREATMENT OUTCOME;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC AGENTS; BARRETT ESOPHAGUS; DIHEMATOPORPHYRIN ETHER; ENDOSCOPY; ESOPHAGEAL NEOPLASMS; HUMANS; MALE; MUCOUS MEMBRANE; PHOTOCHEMOTHERAPY;

EID: 4544266827     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.SMJ.0000136265.34296.62     Document Type: Article

References (41)

1. Spechler SJ. Clinical practice. Barrett's Esophagus. N Engl J Med 2002; 346:836-842.
2. Schroder W, Gutschow CA, Holscher AH. Limited resection for early esophageal cancer? Langenbecks Arch Surg 2003;388:88-94.
3. Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002;346:1128-1137.
4. Patti MG, Corvera CU, Glasgow RE, et al. A hospital's annual rate of esophagectomy influences the operative mortality rate. J Gastrointest Surg 1998;2:186-192.
5. Begg CB, Cramer LD, Hoskins WJ, et al. Impact of hospital volume on operative mortality for major cancer surgery. JAMA 1998;280:1747-1751.
6. Wolfsen HC. Photodynamic therapy for mucosal esophageal adenocarcinoma and dysplastic Barrett's esophagus. Dig Dis 2002;20:5-17.
7. Haringsma J. Barrett's oesophagus: new diagnostic and therapeutic techniques. Scand J Gastroenterol Suppl 2002;(236):9-14.
8. Al-Kasspooles MF, Hill HC, Nava HR, et al. High-grade dysplasia within Barrett's esophagus: controversies regarding clinical opinions and approaches. Ann Surg Oncol 2002;9:222-227.
9. Pacifico RJ, Wang KK. Nonsurgical management of Barrett's esophagus with high-grade dysplasia. Surg Oncol Clin N Am 2002;11:321-336.
10. Sorbi D, Fleischer DE. Nonsurgical approaches to esophageal malignancy. Curr Gastroenterol Rep 2003;5:213-220.
11. Wolfsen HC, Woodward TA, Raimondo M. Photodynamic therapy for dysplastic Barrett esophagus and early esophageal adenocarcinoma. Mayo Clin Proc 2002;77:1176-1181.
12. Ishiguro A, Uno Y, Ishiguro Y, et al. Correlation of lifting versus nonlifting and microscopic depth of invasion in early colorectal cancer. Gastrointest Endosc 1999;50:329-333.
13. Kato H, Haga S, Endo S, et al. Lifting of lesions during endoscopic mucosal resection (EMR) of early colorectal cancer: implications for the assessment of resectability. Endoscopy 2001;33:568-573.
14. Suzuki H. Endoscopic mucosal resection using ligating device for early gastric cancer. Gastrointest Endosc Clin N Am 2001;11:511-518.
15. Hamilton SR, Smith RR. The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus. Am J Clin Pathol 1987;87:301-312.
16. Cameron AJ, Carpenter HA. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study. Am J Gastroenterol 1997;92:586-591.
17. Rice TW, Falk GW, Achkar E, et al. Surgical management of high-grade dysplasia in Barrett's esophagus. Am J Gastroenterol 1993;88:1832-1836.
18. Heitmiller RF, Redmond M, Hamilton SR. Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. Ann Surg 1996;224:66-71.
19. Schnell TG, Sontag SJ, Chejfec G, et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology 2001;120:1607-1619.
20. Spechler SJ. The natural history of dysplasia and cancer in esophagitis and barrett esophagus. J Clin Gastroenterol 2003;36:S2-5.
21. Edwards MJ, Gable DR, Lentsch AB, et al: The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia. Ann Surg 1996;223:585-589; discussion 589-591.
22. Wang KK, Sampliner RE. Mucosal ablation therapy of barrett esophagus. Mayo Clin Proc 2001;76:433-437.
23. Attwood SEA, Lewis CJ, Caplin S, et al. Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett's esophagus. Clin Gastroenterol Hepatol 2003;1:258-263.
24. May A, Gossner L, Pech O, et al. Intraepithelial high-grade neoplasia and early adenocarcinoma in short-segment Barrett's esophagus (SSBE): curative treatment using local endoscopic treatment techniques. Endoscopy 2002;34:604-610.
25. Ell C, May A, Gossner L, et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology 2000;118:670-677.
26. May A, Gossner L, Pech O, et al. Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus: acute-phase and intermediate results of a new treatment approach. Eur J Gastroenterol Hepatol 2002;14:1085-1091.
27. Nijhawan PK, Wang KK. Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high-grade dysplasia within Barrett's esophagus. Gastrointest Endosc 2000;52:328-332.
28. Fitzgerald RC, MCantab MA, Farthing MJG. The pathogenesis of Barrett's esophagus. Gastrointest Endosc Clin N Am 2003;13:233-255.
29. Ginsberg GG. Endoluminal therapy for Barrett's with high-grade dysplasia and early esophageal adenocarcinoma [editorial]. Clin Gastroenterol Hepatol 2003;1:241-245.
30. Ackroyd R, Kelty CJ, Brown NJ, et al. Eradication of dysplastic Barrett's oesophagus using photodynamic therapy: Long-term follow-up. Endoscopy 2003;35:496-501.
31. Overholt BF, Panjehpour M, Haydek JM. Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. Gastrointest Endosc 1999;49:1-7.
32. Hemminger LL, Wolfsen HC. Photodynamic therapy for Barrett's esophagus and high grade dysplasia: results of a patient satisfaction survey. Gastroenterol Nurs 2002;25:139-141.
33. Owens MM, Kimmey MB. The role of endoscopic ultrasound in the diagnosis and management of Barrett's esophagus. Gastrointest Endosc Clin N Am 2003;13:325-334.
34. Stein HJ, Feith M, Mueller J, et al. Limited resection for early adenocarcinoma in Barrett's esophagus. Ann Surg 2000;232:733-742.
35. Schroder W, Monig SP, Baldus SE, et al. Frequency of nodal metastases to the upper mediastinum in Barrett's cancer. Ann Surg Oncol 2002;9: 807-811.
36. Nigro JJ, Hagen JA, DeMeester TR, et al. Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: implications for therapy. J Thorac Cardiovasc Surg 1999;117:16-23; discussion 23-15.
37. Potet F, Flejou JF, Gervaz H, et al. Adenocarcinoma of the lower esophagus and the esophagogastric junction. Semin Diagn Pathol 1991;8: 126-136.
38. Streitz JM Jr, Ellis FH Jr, Gibb SP, et al. Adenocarcinoma in Barrett's esophagus. A clinicopathologic study of 65 cases. Ann Surg 1991;213: 122-125.
39. Montgomery E, Bronner MP, Greenson JK, et al. Are ulcers a marker for invasive carcinoma in Barrett's esophagus? Data from a diagnostic variability study with clinical follow-up. Am J Gastroenterol 2002;97: 27-31.
40. Buttar NS, Wang KK, Lutzke LS, et al. Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett's esophagus. Gastrointest Endosc 2001;54:682-688.
41. Pacifico RJ, Wang KK, Wong Kee Song LM et al. Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett's esophagus. Clin Gastroenterol Hepatol 2003;1:252-257